FP6Индивидуална стипендия2004–2006

CSACGED · Cross-Study Analysis of Cancer Gene Expression Datasets

6РП — Действия „Мария Кюри“

Период
2004-04-01 → 2006-03-31
Финансиране от ЕС
143 454 €
Участници
1
Схема
EIF

Линиите свързват координатора с партньорите.

Накратко на български

Генната експресия при рак на щитовидната жлеза се анализира чрез обединяване на данни от лабораторни проби и реални пациенти. Това помага да се разберат механизмите при развитието на тумори и разликите между радиационно индуцирания и спорадичен рак.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Final Activity Report Summary - CSACGED (Cross-study analysis of cancer gene expression datasets)

A wealth of genome-wide gene expression data is available in public databases. This extraordinary material has been poorly exploited so far. The objective of the project was to develop the integration of high throughput gene expression data in the field of cancer, and in particular thyroid cancer. We found that appropriate methodological approaches alleviate the need to remove study-specific biases, a challenging task, before integrative studies are carried out. Taking advantage of this, we explored a new frontier in data integration: the integration of in vitro and in vivo expression data. In a first study we characterised gene expression after stimulation of normal thyroid cells exposed in vitro to thyroid stimulating hormone (TSH). The steady state expression of TSH-associated genes in vitro resembled that of in vivo autonomous adenomas. The TSH receptor is constitutively activated in these benign tumours. Interestingly, several genes inhibiting the effect of TSH stimulation were expressed in the cultures, but not in the tumours. This suggests that these negative feedbacks are involved in tumourigenesis. It also demonstrates that expression data integration is a powerful tool to characterise quantitatively and objectively in vivo gene expression from gene expression in in vitro systems. The same principle was applied to characterise the genes differentially expressed between Ukrainian post-Chernobyl, radiation-induced, thyroid cancers and sporadic thyroid cancers from France. We reasoned that in the absence of exposure to high radiation levels, the French cancer are due to failure to cope with hydrogen peroxide, a compound produced in large quantities during thyroid hormone synthesis, and also a potent DNA damaging agent. Symmetrically, most people exposed to high-level radiation in the vicinity of the Chernobyl plant did not develop thyroid cancer. Those who did, did so because their thyroid cells failed to repair the damage that radiation caused in their DNA. Thus, different susceptibility factors might underlie French and Ukrainian tumours. We derived from published in vitro data a set of 118 genes that are expressed differently when cells are exposed to radiation and to hydrogen peroxide. We then showed that machine learning algorithms predict accurately whether a tumour is French or Ukrainian on the basis of these 118 genes. We further show that accurate prediction is also possible on the basis of 13 genes involved in the repair of DNA double strand breaks. These results support the existence of a molecular radiation susceptibility signature. Such signature would have a wide range of applications. In addition to its own biological significance, the work carried out during this project suggests that gene expression in well-defined functional in vitro assays could lie at the foundation of a general functional taxonomy of cancers.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Data from an increasing number of high-throughput cancer gene expression studies are becoming available. Few researchers, however, have attempted to integrate these data. We propose to developbioinformatic tools for the cross-study analysis of expression data. We will use them(i) to cross-validate thyroid cancer datasets,(ii) to compare expression in micro dissected tumours and in their cell line counterparts, and (iii) to find shared characteristics between different types of cancers. In addition, theories respond to the need for reuse and integration of gene expression data flowing at an increasing rate into public databases. The applicant was trained in computer and cognitive sciences. His research experience in computer and mathematical modelling in biology led to papers in respected journals, including two PNAS publications. With a history of landmark discoveries and an average of 100 publications per year, the host, IRIBHM, Free University of Brussels, is a leading European lab in thyroid cancer. Its microarray group has been the first to do thyroid cancer microarray in Europe. The applicant has spent his last five research years in the United States and wish to return to Europe.IRIBHM has the critical mass of people and collaborations needed for a successful integration in European research. The pesto will complement his biomathematics experience with expertise in high-throughput data analysis. This skill is an essential step toward the applicant's goal of moving to medical applications. Joining a wet lab after years in computational biology institutions will also extend his biological knowledge.

Оригинален текст от CORDIS (на английски).

Участници

  • UNIVERSITE LIBRE DE BRUXELLES · BRUXELLESКоординаторБелгия

Връзки

Данни: CORDIS, © Европейски съюз